| 000 | 01613 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250514203917.0 | ||
| 264 | 0 | _c20050125 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a0031-7012 | ||
| 024 | 7 |
_a10.1159/000080104 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPatil, Chandrashekhar S | |
| 245 | 0 | 0 |
_aModulatory effect of the PDE-5 inhibitor sildenafil in diabetic neuropathy. _h[electronic resource] |
| 260 |
_bPharmacology _cNov 2004 |
||
| 300 |
_a190-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_a3',5'-Cyclic-GMP Phosphodiesterases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCyclic Nucleotide Phosphodiesterases, Type 5 |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xcomplications |
| 650 | 0 | 4 |
_aDiabetic Neuropathies _xcomplications |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHyperalgesia _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylene Blue _xpharmacology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xpharmacology |
| 650 | 0 | 4 |
_aPain Threshold _xdrug effects |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aPiperazines _xtherapeutic use |
| 650 | 0 | 4 | _aPurines |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aSildenafil Citrate |
| 650 | 0 | 4 | _aSulfones |
| 700 | 1 | _aSingh, Vijay Pal | |
| 700 | 1 | _aSingh, Sukhjeet | |
| 700 | 1 | _aKulkarni, Shrinivas K | |
| 773 | 0 |
_tPharmacology _gvol. 72 _gno. 3 _gp. 190-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000080104 _zAvailable from publisher's website |
| 999 |
_c15144816 _d15144816 |
||